Ubs Group Ag Vaxcyte, Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 95,676 shares of PCVX stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

95,676

Previous 176,078 45.66%

Holding current value

$10.1 Million

Previous $12 Million 39.94%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$60.06 - $78.77 $4.83 Million - $6.33 Million	-80,402 Reduced 45.66%	95,676 $7.22 Million
Q1 2024 May 13, 2024	BUY	$59.79 - $81.05 $600,530 - $814,066	10,044 Added 6.05%	176,078 $12 Million
Q4 2023 Feb 09, 2024	BUY	$45.35 - $63.41 $4.16 Million - $5.82 Million	91,729 Added 123.45%	166,034 $10.4 Million
Q3 2023 Nov 09, 2023	BUY	$46.0 - $53.1 $1.31 Million - $1.51 Million	28,483 Added 62.16%	74,305 $3.79 Million
Q2 2023 Aug 11, 2023	BUY	$34.66 - $54.07 $1.58 Million - $2.46 Million	45,478 Added 13220.35%	45,822 $2.29 Million
Q1 2023 May 12, 2023	SELL	$36.27 - $47.2 $4.44 Million - $5.78 Million	-122,376 Reduced 99.72%	344 $12,000
Q4 2022 Feb 08, 2023	BUY	$20.58 - $47.95 $2.52 Million - $5.88 Million	122,645 Added 163526.67%	122,720 $5.88 Million
Q3 2022 Nov 10, 2022	SELL	$21.69 - $28.53 $509,671 - $670,397	-23,498 Reduced 99.68%	75 $2,000
Q2 2022 Aug 10, 2022	SELL	$17.68 - $26.58 $650,871 - $978,516	-36,814 Reduced 60.96%	23,573 $513,000
Q1 2022 May 16, 2022	BUY	$17.46 - $26.36 $264,553 - $399,406	15,152 Added 33.5%	60,387 $1.46 Million
Q4 2021 Feb 14, 2022	SELL	$19.32 - $26.45 $1.48 Million - $2.02 Million	-76,552 Reduced 62.86%	45,235 $1.08 Million
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $281,289 - $374,451	13,884 Added 12.87%	121,787 $3.09 Million
Q2 2021 Aug 13, 2021	SELL	$16.45 - $24.06 $124,148 - $181,580	-7,547 Reduced 6.54%	107,903 $2.43 Million
Q1 2021 May 12, 2021	BUY	$18.66 - $29.16 $882,319 - $1.38 Million	47,284 Added 69.37%	115,450 $2.28 Million
Q4 2020 Feb 11, 2021	BUY	$26.57 - $51.74 $1.79 Million - $3.49 Million	67,446 Added 9367.5%	68,166 $1.81 Million
Q3 2020 Nov 12, 2020	BUY	$26.5 - $55.4 $19,080 - $39,888	720 New	720 $36,000

Others Institutions Holding PCVX

# of Institutions

290

Shares Held

110M

Call Options Held

248K

Put Options Held

109K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $6.26B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account